New infection with heterotypic hepatitis C virus in a patient with long-term hepatitis C virus eradication

被引:6
作者
De Mitri, MS
Cassini, R
Morsica, G
Bagaglio, S
Zoli, M
Bernardi, M
机构
[1] Univ Bologna, Dept Internal Med, I-40126 Bologna, Italy
[2] San Raffaele Sci Inst, Dept Infect Dis, I-20132 Milan, Italy
关键词
chronic hepatitis; genotype; hepatitis C virus; interferon;
D O I
10.1016/S1590-8658(01)80113-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Experimental hepatitis C virus infection in chimpanzees has shown that natural hepatitis C virus infection does not induce protective immunity and reinfection can occur in seroconverted animals. Aim. To study the clinical, virological and histological outcome of a new infection sustained by a different hepatitis C virus strain after a primary infection with eradication of the original virus. Patients and methods. A young Italian man with chronic hepatitis C virus type 4 hepatitis was treated with Interferon therapy and achieved a sustained biochemical and virological response. After long follow-up, an asymptomatic flare-up of alanine transaminase occurred. This alanine transaminase increase was associated with serum hepatitis C virus PNA positivity and a low viral load, and the infecting hepatitis C virus genotype was type 3. The clinical and virological course of this new infection is described. Results and Conclusions. This report shows that there is no protective immunity against hepatitis C virus type 3 after infection by hepatitis C virus type 4 strain.
引用
收藏
页码:591 / 594
页数:4
相关论文
共 26 条
[1]  
De Mitri RS, 2000, J MED VIROL, V60, P133, DOI 10.1002/(SICI)1096-9071(200002)60:2&lt
[2]  
133::AID-JMV5&gt
[3]  
3.0.CO
[4]  
2-Q
[5]  
DeMitri MS, 1997, ITAL J GASTROENTEROL, V29, P255
[6]   LACK OF PROTECTIVE IMMUNITY AGAINST REINFECTION WITH HEPATITIS-C VIRUS [J].
FARCI, P ;
ALTER, HJ ;
GOVINDARAJAN, S ;
WONG, DC ;
ENGLE, R ;
LESNIEWSKI, RR ;
MUSHAHWAR, IK ;
DESAI, SM ;
MILLER, RH ;
OGATA, N ;
PURCELL, RH .
SCIENCE, 1992, 258 (5079) :135-140
[7]  
GonzalezPeralta RP, 1996, J MED VIROL, V49, P242, DOI 10.1002/(SICI)1096-9071(199607)49:3<242::AID-JMV14>3.0.CO
[8]  
2-E
[9]  
Hashimoto M, 1999, J MED VIROL, V58, P247, DOI 10.1002/(SICI)1096-9071(199907)58:3&lt
[10]  
247::AID-JMV10&gt